Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 4/20 | 0.39 |
| ▸ | MMP3 | P08254 | 2/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 5/20 | 0.36 |
| ▸ | IL2 | P60568 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | GHSR | Q92847 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | USP5 | P45974 | 1/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4834001 | 0.91 | ALOX5 (0.41) | MMP8MMP3RORCIL2FFAR4 | |
| SCHEMBL4837354 | 0.91 | MAPT (0.39) | MMP8MMP3RORCIL2FFAR4 | |
| SCHEMBL4845420 | 0.90 | FFAR4 (0.43) | MMP8MMP3RXRARXRBRXRG | |
| SCHEMBL4841606 | 0.90 | FFAR4 (0.43) | MMP8MMP3RXRARXRBRXRG | |
| SCHEMBL4841575 | 0.88 | MAPT (0.39) | MMP8MMP3RORCIL2FFAR4 | |
| SCHEMBL4845042 | 0.87 | PPARD (0.41) | MMP8MMP3RXRARXRBRXRG | |
| SCHEMBL4837871 | 0.87 | MAPT (0.38) | MMP8MMP3RORCIL2FFAR4 | |
| SCHEMBL4838970 | 0.86 | PPARD (0.39) | MMP8MMP3RXRARXRBRXRG | |
| SCHEMBL4833071 | 0.85 | PTGDR2 (0.40) | MMP8RXRARXRBRXRGFFAR4 | |
| SCHEMBL4842938 | 0.84 | ALOX5 (0.41) | MMP8MMP3RORCFFAR4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | CRHR1 983/4885MMP8 3968/4885MMP3 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.